Perinatal Depression Triples Risk for Suicidal Behavior
2024-01-12
临床结果
FRIDAY, Jan. 12, 2024 -- Mothers with clinically diagnosed perinatal depression (PND) had a three times higher risk for suicidal behavior than mothers without perinatal depression, according to a study published online Jan. 9 in JAMA Network Open.
Hang Yu, from the Karolinska Institutet in Stockholm, and colleagues examined the association between PND and risk for short- and long-term suicidal behavior. The analysis included 86,551 women with PND (2001 to 2017) and 865,510 unaffected women individually matched on age and calendar year at delivery.
During a median 6.91 years of follow-up, the researchers found that more events of suicidal behavior (incidence rate [IR], 5.62 per 1,000 person-years) were identified among women with PND compared with unaffected women (IR, 1.01 per 1,000 person-years). Compared with unaffected women, women with PND also had an elevated risk for suicidal behavior (hazard ratio [HR], 3.15). Risk was somewhat attenuated when comparing PND women with their PND-free sisters (HR, 2.75). In a matched analysis, the association was greater for postnatal depression and among women without a history of psychiatric disorders. In the first year after diagnosis, the excess risk was pronounced (HR, 7.20), but remained statistically significant over five to 18 years of follow-up (HR, 2.34).
"These findings suggest that vigilant clinical monitoring and interventions are needed for this vulnerable population to prevent such devastating events," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。